Literature DB >> 2981786

HSV-1 quantitation from rabbit neural tissues after epinephrine-induced reactivation.

Y Shimomura, J B Dudley, L P Gangarosa, J M Hill.   

Abstract

Epinephrine iontophoresis into the eye can induce ocular herpes simplex virus type-1 (HSV-1) shedding with a high frequency from latently infected rabbits. The present study was designed to qualify and quantify infectious HSV-1 from neural tissues of latently infected rabbits after ocular epinephrine iontophoresis. Epinephrine iontophoresis was performed daily for 3 consecutive days on selected days during 220-227 days postinoculation. The induced ocular shedding was detected in the tear film with a frequency of 83% (10/12) within 72 hr after the initial iontophoresis. The rabbits were killed 24 hr after the last iontophoretic treatment, and the corneas and neural tissues were homogenized immediately. The cell-free supernatants were inoculated on primary rabbit kidney cell monolayers for qualitative assays of infectious virus and later titrated on CV-1 monolayers. The frequencies of the recovery of infectious HSV-1 from the cell-free homogenates were 0% of the corneas (0/12), 83% (10/12) from the superior cervical ganglion (SCG), 100% (12/12) from the trigeminal ganglion (TG), 42% (5/12) from the ophthalmic branch of the trigeminal nerve (TN), 8% (1/12) from the root entry zone of the trigeminal nerve into the brain-stem (REZ), and 0% (0/12) from the cerebellum. The authors conclude that epinephrine iontophoresis can reactivate the latent HSV-1 in neural tissues and infectious virus can be quantified from the cell-free homogenates. To the best of our knowledge, this is the first report to quantify HSV-1 with a high frequency from neural tissues following induced reactivation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981786

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Herpes simplex virus type 1 strain KOS-63 does not cause acute or recurrent ocular disease and does not reactivate ganglionic latency in vivo.

Authors:  W G Stroop; M C Banks
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 2.  Animal models of herpes simplex virus immunity and pathogenesis.

Authors:  Christina M Kollias; Richard B Huneke; Brian Wigdahl; Stephen R Jennings
Journal:  J Neurovirol       Date:  2014-11-12       Impact factor: 2.643

3.  Herpes simplex virus type 1 latently infected neurons differentially express latency-associated and ICP0 transcripts.

Authors:  Séverine Maillet; Thierry Naas; Sophie Crepin; Anne-Marie Roque-Afonso; Florence Lafay; Stacey Efstathiou; Marc Labetoulle
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  HSV-1 latent rabbits shed viral DNA into their saliva.

Authors:  James M Hill; Nicole M Nolan; Harris E McFerrin; Christian Clement; Timothy P Foster; William P Halford; Konstantin G Kousoulas; Walter J Lukiw; Hilary W Thompson; Ethan M Stern; Partha S Bhattacharjee
Journal:  Virol J       Date:  2012-09-28       Impact factor: 4.099

5.  The Characteristics of Herpes Simplex Virus Type 1 Infection in Rhesus Macaques and the Associated Pathological Features.

Authors:  Shengtao Fan; Hongzhi Cai; Xingli Xu; Min Feng; Lichun Wang; Yun Liao; Ying Zhang; Zhanlong He; Fengmei Yang; Wenhai Yu; Jingjing Wang; Jumin Zhou; Qihan Li
Journal:  Viruses       Date:  2017-01-30       Impact factor: 5.048

Review 6.  The Role of Herpes Simplex Virus Type 1 Infection in Demyelination of the Central Nervous System.

Authors:  Raquel Bello-Morales; Sabina Andreu; José Antonio López-Guerrero
Journal:  Int J Mol Sci       Date:  2020-07-16       Impact factor: 5.923

Review 7.  Rabbit and mouse models of HSV-1 latency, reactivation, and recurrent eye diseases.

Authors:  Jody M Webre; James M Hill; Nicole M Nolan; Christian Clement; Harris E McFerrin; Partha S Bhattacharjee; Victor Hsia; Donna M Neumann; Timothy P Foster; Walter J Lukiw; Hilary W Thompson
Journal:  J Biomed Biotechnol       Date:  2012-10-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.